Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment

References

1. 1.↵
   2. Kumar N

   . Neuroimaging in superficial siderosis: an in-depth look. AJNR Am J Neuroradiol 2010;31:5–14 doi:10.3174/ajnr.A1628 pmid:19729538

   Abstract/FREE Full Text
2. 2.↵
   2. Linn J,
   3. Herms J,
   4. Dichgans M, et al

   . Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 2008;29:184–86 doi:10.3174/ajnr.A0783 pmid:17947366

   Abstract/FREE Full Text
3. 3.↵
   2. Feldman HH,
   3. Maia LF,
   4. Mackenzie IR, et al

   . Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 2008;39:2894–97 doi:10.1161/STROKEAHA.107.510826 pmid:18635858

   Abstract/FREE Full Text
4. 4.↵
   2. Linn J,
   3. Wollenweber FA,
   4. Lummel N, et al

   . Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 2013;260:176–81 doi:10.1007/s00415-012-6610-7 pmid:22820723

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Charidimou A,
   3. Peeters AP,
   4. Jäger R, et al

   . Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013;81:1666–73 doi:10.1212/01.wnl.0000435298.80023.7a pmid:24107862

   Abstract/FREE Full Text
6. 6.↵
   2. Zonneveld HI,
   3. Goos JD,
   4. Wattjes MP, et al

   . Prevalence of cortical superficial siderosis in a memory clinic population. Neurology 2014;82:698–704 doi:10.1212/WNL.0000000000000150 pmid:24477113

   Abstract/FREE Full Text
7. 7.↵
   2. Wollenweber FA,
   3. Buerger K,
   4. Mueller C, et al

   . Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol 2014;261:277–82 doi:10.1007/s00415-013-7181-y pmid:24221645

   CrossRefPubMed
8. 8.↵
   2. Charidimou A,
   3. Gang Q,
   4. Werring DJ

   . Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012;83:124–37 doi:10.1136/jnnp-2011-301308 pmid:22056963

   Abstract/FREE Full Text
9. 9.↵
   2. Ellis RJ,
   3. Olichney JM,
   4. Thal LJ, et al

   . Cerebral amyloid angiopathy in brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996;46:1592–96 doi:10.1212/WNL.46.6.1592 pmid:8649554

   Abstract/FREE Full Text
10. 10.↵
    2. Yamada M

    . Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 2002;977:37–44 doi:10.1111/j.1749-6632.2002.tb04797.x pmid:12480732

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Uetani H,
    3. Hirai T,
    4. Hashimoto M, et al

    . Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia. AJNR Am J Neuroradiol 2013;34:984–89 doi:10.3174/ajnr.A3332 pmid:23124636

    Abstract/FREE Full Text
12. 12.↵
    2. McKhann G,
    3. Drachman D,
    4. Folstein M, et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44 doi:10.1212/WNL.34.7.939 pmid:6610841

    Abstract/FREE Full Text
13. 13.↵
    2. Román GC,
    3. Tatemichi TK,
    4. Erkinjuntti T, et al

    . Vascular dementia: diagnostic criteria for research studies—report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–60 doi:10.1212/WNL.43.2.250 pmid:8094895

    Abstract/FREE Full Text
14. 14.↵
    2. Winblad B,
    3. Palmer K,
    4. Kivipelto M, et al

    . Mild cognitive impairment beyond controversies—towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–46 doi:10.1111/j.1365-2796.2004.01380.x pmid:15324367

    CrossRefPubMedWeb of Science
15. 15.↵
    2. McKeith IG,
    3. Galasko D,
    4. Kosaka K, et al

    . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–24 doi:10.1212/WNL.47.5.1113 pmid:8909416

    Abstract/FREE Full Text
16. 16.↵
    2. Neary D,
    3. Snowden JS,
    4. Gustafson L, et al

    . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54 doi:10.1212/WNL.51.6.1546 pmid:9855500

    Abstract/FREE Full Text
17. 17.↵
    2. Fazekas F,
    3. Chawluk JB,
    4. Alavi A, et al

    . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Wahlund LO,
    3. Barkhof F,
    4. Fazekas F, et al

    ; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318–22 doi:10.1161/01.STR.32.6.1318 pmid:11387493

    Abstract/FREE Full Text
19. 19.↵
    2. Evans DA,
    3. Funkenstein HH,
    4. Albert MS, et al

    . Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551–56 doi:10.1001/jama.1989.03430180093036 pmid:2810583

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Jorm AF,
    3. Korten AE,
    4. Henderson AS

    . The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465–79 doi:10.1111/j.1600-0447.1987.tb02906.x pmid:3324647

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Rocca WA,
    3. Amaducci LA,
    4. Schoenberg BS

    . Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986;19:415–24 doi:10.1002/ana.410190502 pmid:3717905

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Gao S,
    3. Hendrie HC,
    4. Hall KS, et al

    . The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998;55:809–15 doi:10.1001/archpsyc.55.9.809 pmid:9736007

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Lindsay J,
    3. Laurin D,
    4. Verreault R, et al

    . Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445–53 doi:10.1093/aje/kwf074 pmid:12196314

    Abstract/FREE Full Text
24. 24.↵
    2. Fazekas F,
    3. Kleinert R,
    4. Roob G, et al

    . Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637–42 pmid:10319975

    Abstract/FREE Full Text
25. 25.↵
    2. Mesker DJ,
    3. Poels MM,
    4. Ikram MA, et al

    . Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2011;68:656–59 doi:10.1001/archneurol.2011.93 pmid:21555643

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Shams S,
    3. Martola J,
    4. Granberg T, et al

    . Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis—the Karolinska Imaging Dementia Study. AJNR Am J Neuroradiol 2015;36:661–66 doi:10.3174/ajnr.A4176 pmid:25523590

    Abstract/FREE Full Text
27. 27.↵
    2. Esiri MM,
    3. Wilcock GK

    . Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 1986;49:1221–26 doi:10.1136/jnnp.49.11.1221 pmid:3794727

    Abstract/FREE Full Text
28. 28.↵
    2. De Reuck J,
    3. Deramecourt V,
    4. Cordonnier C, et al

    . Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study. J Neurol Sci 2011;300:63–66 doi:10.1016/j.jns.2010.09.031 pmid:20965516

    CrossRefPubMed
29. 29.↵
    2. De Reuck J,
    3. Deramecourt V,
    4. Cordonnier C, et al

    . Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. Eur J Neurol 2012;19:1355–60 doi:10.1111/j.1468-1331.2012.03776.x pmid:22642502

    CrossRefPubMed
30. 30.↵
    2. Markesbery WR

    . Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 2010;19:221–28 doi:10.3233/JAD-2010-1220 pmid:20061641

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Kumar S,
    3. Goddeau RP Jr.,
    4. Selim MH, et al

    . Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010;74:893–99 doi:10.1212/WNL.0b013e3181d55efa pmid:20231664

    Abstract/FREE Full Text
32. 32.↵
    2. Pettersen JA,
    3. Sathiyamoorthy G,
    4. Gao FQ, et al

    . Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 2008;65:790–95 doi:10.1001/archneur.65.6.790 pmid:18541799

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Knudsen KA,
    3. Rosand J,
    4. Karluk D, et al

    . Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537–39 doi:10.1212/WNL.56.4.537 pmid:11222803

    Abstract/FREE Full Text
34. 34.↵
    2. Shoamanesh A,
    3. Martinez-Ramirez S,
    4. Oliveira-Filho J, et al

    . Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology 2014;83:1838–43 doi:10.1212/WNL.0000000000000984 pmid:25320098

    Abstract/FREE Full Text